Special Issue "Delivery and Genomics of Large Molecules"

Guest Editor
Prof. Dr. David A Jans
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia
Website: http://www.med.monash.edu.au/biochem/staff/jans.html
E-Mail: david.jans@med.monash.edu.au

Guest Editor
Dr. Kylie Wagstaff
Nuclear Signalling Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia
Website: http://www.med.monash.edu.au/biochem/nuclear-signalling-page-jans.html
E-Mail: kylie.wagstaff@med.monash.edu.au

Dear Colleagues,

Both the study and treatment of numerous diseases require the delivery of large molecules to cells/tissues in a specific/controlled fashion. For example, during gene therapy applications, large pieces of DNA encoding multiple therapeutic genes (ranging in size from small plasmids to mini-chormosomes) must be delivered to the nuclei of specific cells to treat inherited or acquired disorders. Numerous complications arise from attempting to deliver such large macromolelcules meaning that considerations such as packaging, including the ability to coat and if necessary uncoat in controlled fashion, as well as delivery through numerous cellular and tissue specific barriers must be taken into account in the design of such systems. For instance, in the gene therapy example one must not only take into account the design and regulation of the genes encoded in the therapeutic vector, but also examine how the DNA is going to be condensed and protected from degradation and how it will traverse across the plasma membrane, through the crowded cytoplasm and across the nuclear envelope before being transcribed in the nucleus in regulated fashion. These challenges and many more define the field of large molecule delivery and will be the mainstay of work in this area for many years.

Prof. Dr. David A Jans
Dr. Kylie Wagstaff
Guest Editors

Related Journal

• Genes - an Open Access journal of genetics and genomics.

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.

• gene delivery
• drug delivery
• gene therapy
• phenomics
• nuclear transport
• gene transfer
• intracellular transport